A Study of Azacitidine for Patients With Int/High -Risk MDS and AML-MRC

Clinical trial NCT03978364 · UNKNOWN

Trial details

NCT number: NCT03978364
Sponsor: Shandong Provincial Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Myelodysplastic Syndromes,Acute Myeloid Leukemia

Start date: 2019-06-01
Primary completion: 2022-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.